Cargando…

The Effectiveness and Safety of Pharmaceutical-Grade Cannabidiol in the Treatment of Mastocytosis-Associated Pain: A Pilot Study

Mastocytosis patients often experience a number of symptoms, including mastocytosis-associated pain that is difficult to manage due to resistance to usual antalgic treatments and/or the patient’s poor tolerance. Mastocytosis patients display significantly higher levels of indoleamine-2,3-dioxygenase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossignol, Julien, Hatton, Séverine, Ridley, Ashley, Hermine, Olivier, Greco, Céline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953706/ https://www.ncbi.nlm.nih.gov/pubmed/36831056 http://dx.doi.org/10.3390/biomedicines11020520

Ejemplares similares

Recent advances in the understanding and therapeutic management of mastocytosis
por: Rossignol, Julien, et al.
Publicado: (2019)

Targeted Treatment Options in Mastocytosis
por: Vaes, Mélanie, et al.
Publicado: (2017)

Clinical potential of midostaurin in advanced systemic mastocytosis
por: Chandesris, Marie Olivia, et al.
Publicado: (2017)

Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy
por: Wheless, James W., et al.
Publicado: (2019)

Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis
por: Reiter, Andreas, et al.
Publicado: (2022)

Evidence for Cognitive Impairment in Mastocytosis: Prevalence, Features and Correlations to Depression
por: Moura, Daniela Silva, et al.
Publicado: (2012)

Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy
por: Moura, Daniela Silva, et al.
Publicado: (2011)

A French National Survey on Clotting Disorders in Mastocytosis
por: Carvalhosa, Ana B., et al.
Publicado: (2015)

Neuroimaging evidence of brain abnormalities in mastocytosis
por: Boddaert, N, et al.
Publicado: (2017)

Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review
por: Villanueva, Maria Resah B, et al.
Publicado: (2022)

Melanoma and Mastocytosis
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

P994: HEDGEHOG PATHWAY INVOLVEMENT IN MASTOCYTOSIS DEVELOPMENT
por: Polivka, L., et al.
Publicado: (2022)

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
por: Gotlib, Jason, et al.
Publicado: (2021)

Phenotypic and Genotypic Characteristics of Mastocytosis According to the Age of Onset
por: Lanternier, Fanny, et al.
Publicado: (2008)

Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis
por: Hermine, Olivier, et al.
Publicado: (2008)

Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis
por: Kluin-Nelemans, Hanneke C., et al.
Publicado: (2021)

Pediatric Mastocytosis: An Update
por: Giona, Fiorina
Publicado: (2021)

Cutaneous mastocytosis in childhood
por: Nemat, Katja, et al.
Publicado: (2022)

Avapritinib for Cutaneous Mastocytosis
por: LEE, Hannah, et al.
Publicado: (2021)

Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts
por: Valent, Peter, et al.
Publicado: (2023)

Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs
por: Garcia, Gabriel A., et al.
Publicado: (2022)

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
por: Bonadonna, Patrizia, et al.
Publicado: (2021)

Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action
por: Mlost, Jakub, et al.
Publicado: (2020)

Current Concepts on Diagnosis and Treatment of Mastocytosis
por: Magliacane, D., et al.
Publicado: (2014)

The Role of Avapritinib for the Treatment of Systemic Mastocytosis
por: Sumbly, Vikram, et al.
Publicado: (2021)

Treatment of Indolent and Advanced Systemic Mastocytosis
por: Buonomo, Alessandro, et al.
Publicado: (2022)

Primary cutaneous lymphoma in a patient with mastocytosis: Is there an association?
por: Kincaid, Colin M., et al.
Publicado: (2023)

Neuropilin-1 Expression Characterizes T Follicular Helper (Tfh) Cells Activated during B Cell Differentiation in Human Secondary Lymphoid Organs
por: Renand, Amédée, et al.
Publicado: (2013)

Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)
por: Boehnke, Kevin F., et al.
Publicado: (2022)

An elusive case of systemic mastocytosis
por: Lee, JK, et al.
Publicado: (2010)

Mastocytosis in the skin in children and adults
por: Lange, Magdalena
Publicado: (2015)

Systemic Mastocytosis: Multidisciplinary Approach
por: Zanotti, Roberta, et al.
Publicado: (2021)

Precision Medicine in Systemic Mastocytosis
por: Nicolosi, Maura, et al.
Publicado: (2021)

Anaesthesia in a patient with mastocytosis
por: Maheshwari, Shivi, et al.
Publicado: (2022)

Systemic Lymphadenopathic Mastocytosis with Eosinophilia
por: Im, Soyoung, et al.
Publicado: (2022)

Childhood Cutaneous Mastocytosis: Revisited
por: Swarnkar, Bhavya, et al.
Publicado: (2023)

Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM)
por: Ciach, Katarzyna, et al.
Publicado: (2016)

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial
por: DeAngelo, Daniel J., et al.
Publicado: (2021)

Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs
por: Gamble, Lauri-Jo, et al.
Publicado: (2018)

Case Report: Treatment of systemic mastocytosis with sunitinib
por: Molderings, Gerhard J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pv6sj215c25m2q86a9oec7gqn7